| Authors: |
Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Martini A; Department of Urology, University of Cincinnati, Cincinnati, OH, USA., Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands., Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Maxim Bruins H; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia., Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Seles M; Department of Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Seisen T; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skaanes Universitetssjukhus, Malmö, Sweden., Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, London, UK., Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Sheikh SE; Department of Pathology, Royal Free London NHS Foundation Trust, London, UK., Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, London, UK., Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP and Pierre et Marie Curie Medical School, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia., Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany., de Kaa CAH; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LALM; IQ Health and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia., Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Hurle R; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Paciotti M; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy., Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Pradere B; Department of Urology UROSUD, La Croix du Sud Hôpital, Quint Fonsegrives, France., Perdonà S; Uro-Gynecological Department, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, Naples, Italy., Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands., Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl. |
